⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14014341 | 0.79 | — | — | |
| SCHEMBL16363793 | 0.77 | S100A4 (0.42) | — | |
| SCHEMBL91997 | 0.75 | — | — | |
| SCHEMBL31556280 | 0.75 | — | — | |
| SCHEMBL406747 | 0.75 | — | — | |
| SCHEMBL24351813 | 0.72 | ALDH1A1 (0.48) | — | |
| SCHEMBL10211770 | 0.72 | — | — | |
| SCHEMBL171133 | 0.72 | — | — | |
| SCHEMBL167920 | 0.72 | — | — | |
| SCHEMBL29719717 | 0.72 | NOTUM (0.53) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101522200-A | Topical formulations of borinic acid antibodies and their methods of use | ANACOR PHARMACEUTICALS INC (US) | 2009-09-02 | — | — | CN | claimed |
| WO-2024050708-A1 | BLUE LIGHT EMITTING GUEST MATERIAL AND USE | 北京大学深圳研究生院 | 2024-03-14 | — | — | WO | disclosed |
| US-20230150254-A1 | ON-PRESS DEVELOPMENT TYPE LITHOGRAPHIC PRINTING PLATE PRECURSOR, METHOD OF PREPARING LITHOGRAPHIC PRINTING PLATE, AND LITHOGRAPHIC PRINTING METHOD | FUJIFILM CORPORATION (JP) | 2023-05-18 | — | — | US | disclosed |
| US-20230131749-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LT MATERIALS CO., LTD. (KR) | 2023-04-27 | — | — | US | disclosed |
| CN-110452216-A | Anti-fibrosis pyridinone | INTERMUNE INC | 2019-11-15 | — | — | CN | disclosed |
| CN-106459042-B | Anti-fibrotic pyridinones | 英特穆恩公司 | 2019-06-28 | — | — | CN | disclosed |
| US-20170358750-A1 | HOLE TRANSPORT MATERIALS | LG CHEM, LTD. (KR) | 2017-12-14 | — | — | US | disclosed |
| EP-3184590-A1 | COLOR DEVELOPING COMPOSITION, LITHOGRAPHIC PRINTING ORIGINAL PLATE, METHOD FOR MAKING LITHOGRAPHIC PRINTING PLATE, AND COLOR DEVELOPER | Fujifilm Corporation (JP) | 2017-06-28 | — | — | EP | disclosed |
| CN-106459042-A | Anti-fibrotic pyridinones | 英特穆恩公司 | 2017-02-22 | — | — | CN | disclosed |
| WO-2017019819-A1 | FACTOR XIA MACROCYCLIC INHIBITORS BEARING ALKYL OR CYCLOALKYL P2' MOIETIES | BRISTOL-MYERS SQUIBB COMPANY (US) | 2017-02-02 | — | — | WO | disclosed |
| EP-2644380-B1 | Lithographic printing plate precursor | FUJIFILM CORP (JP) | 2016-06-15 | — | — | EP | disclosed |
| WO-2014201173-A1 | BICYCLIC SULFONAMIDE COMPOUNDS AS SODIUM CHANNEL INHIBITORS | AMGEN INC. (US) | 2014-12-18 | — | — | WO | disclosed |
| CN-103037867-A | Borinic compositions | COLGATE PALMOLIVE CO | 2013-04-10 | — | — | CN | disclosed |
| CN-102781519-A | Boronic acid compositions | COLGATE PALMOLIVE CO | 2012-11-14 | — | — | CN | disclosed |
| US-20120015966-A1 | PPAR ACTIVE COMPOUNDS | PLEXXIKON INC | 2012-01-19 | — | — | US | disclosed |
| CN-101522200-A | Topical formulations of borinic acid antibodies and their methods of use | ANACOR PHARMACEUTICALS INC (US) | 2009-09-02 | — | — | CN | disclosed |
| US-20080221127-A1 | peroxisome proliferator-activated receptor agonists; congestive heart failure, atherosclerosis, arteriosclerosis, obesity, hyperlipidemia, hypoalphalipoproteinemia, Syndrome X, diabetes, insulin resistance | PLEXXIKON INC | 2008-09-11 | — | — | US | disclosed |
| WO-2006116157-A9 | DIPEPTIDYL PEPTIDASE-IV INHIBITORS | ALANTOS PHARMACEUTICALS INC (US) | 2007-03-01 | — | — | WO | disclosed |